85 related articles for article (PubMed ID: 1701500)
41. Circulating hemopoietic progenitors mobilized by cancer chemotherapy and by rhGM-CSF in the treatment of high-grade non-Hodgkin's lymphoma.
Bregni M; Siena S; Magni M; Bonadonna G; Gianni AM
Leukemia; 1991; 5 Suppl 1():123-7. PubMed ID: 1716335
[No Abstract] [Full Text] [Related]
42. Effect of continuous subcutaneous administration of a small dose of granulocyte colony stimulating factor (G-CSF) by the use of a portable infusion pump in patients with non-Hodgkin's lymphoma receiving chemotherapy.
Furuya H; Wakayama T; Ohguni S; Yamauchi K; Tanaka J; Hatazoe T; Kato Y
Int J Hematol; 1995 Apr; 61(3):123-9. PubMed ID: 7541257
[TBL] [Abstract][Full Text] [Related]
43. [Effect of rG-CSF on the morphology and function of neutrophils in ovarian cancer chemotherapy].
Hoshino T; Suzuki Y; Adachi T; Okabe K; Takayama M
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Nov; 45(11):1320-4. PubMed ID: 7505028
[TBL] [Abstract][Full Text] [Related]
44. Viability and quantification of progenitor cells in venesected blood from patients receiving escalated-dose epirubicin and cyclophosphamide with G-CSF for lymphoma: potential role in further increasing dose-intensity.
O'Flaherty E; Cebon J; Grigg AP
Leuk Lymphoma; 1997 Oct; 27(3-4):343-9. PubMed ID: 9402332
[TBL] [Abstract][Full Text] [Related]
45. Reduced response to granulocyte colony-stimulating factor in W/Wv and Sl/Sld mice.
Cynshi O; Satoh K; Shimonaka Y; Hattori K; Nomura H; Imai N; Hirashima K
Leukemia; 1991 Jan; 5(1):75-7. PubMed ID: 1705639
[TBL] [Abstract][Full Text] [Related]
46. Granulocyte colony-stimulating factor (G-CSF)-induced mobilization of circulating haemopoietic stem cells.
Teshima T; Harada M; Takamatsu Y; Makino K; Inaba S; Akashi K; Kondo S; Tanaka T; Ishii E; Niho Y
Br J Haematol; 1993 Aug; 84(4):570-3. PubMed ID: 7692934
[TBL] [Abstract][Full Text] [Related]
47. Autotransplantation of peripheral blood stem cells mobilized by chemotherapy and recombinant human granulocyte colony-stimulating factor in childhood neuroblastoma and non-Hodgkin's lymphoma.
Fukuda M; Kojima S; Matsumoto K; Matsuyama T
Br J Haematol; 1992 Mar; 80(3):327-31. PubMed ID: 1374627
[TBL] [Abstract][Full Text] [Related]
48. Detecting of the minimal residual disease contaminated in peripheral blood stem cell transplantation in the B-cell malignant lymphoma patients.
Nagasu M; Aizawa S; Hojo H; Tsuda A; Yaguchi M; Nakano M; Toyama K
Am J Hematol; 1992 Oct; 41(2):107-12. PubMed ID: 1384313
[TBL] [Abstract][Full Text] [Related]
49. Interstitial pneumonitis related to granulocyte colony-stimulating factor administration following chemotherapy for elderly patients with non-Hodgkin's lymphoma.
Hasegawa Y; Ninomiya H; Kamoshita M; Ohtani K; Kobayashi T; Kojima H; Nagasawa T; Abe T
Intern Med; 1997 May; 36(5):360-4. PubMed ID: 9213175
[TBL] [Abstract][Full Text] [Related]
50. Clinical oncology: case presentations from oncology centres. Intensive treatment of poor prognosis gastrointestinal lymphoma.
Pettengell R; Bishop PW; Crowther D
Eur J Cancer; 1992; 28A(10):1742-7. PubMed ID: 1382496
[No Abstract] [Full Text] [Related]
51. The capacity of peripheral blood stem cells mobilised with chemotherapy plus G-CSF to repopulate irradiated marrow stroma in vitro is similar to that of bone marrow.
Demuynck H; Pettengell R; de Campos E; Dexter TM; Testa NG
Eur J Cancer; 1992; 28(2-3):381-6. PubMed ID: 1375485
[TBL] [Abstract][Full Text] [Related]
52. Peripheral blood expansion of early progenitor cells after high-dose cyclophosphamide and rhGM-CSF.
Tarella C; Ferrero D; Bregni M; Siena S; Gallo E; Pileri A; Gianni AM
Eur J Cancer; 1991; 27(1):22-7. PubMed ID: 1826435
[TBL] [Abstract][Full Text] [Related]
53. In vivo dose-response effect of recombinant human granulocyte colony-stimulating factor on increase in granulocytes after peripheral blood stem cell autotransplantation.
Takaue Y; Koyama T; Watanabe T; Kawano Y; Ninomiya T; Kuroda Y; Hiraoka A; Masaoka T
Acta Haematol; 1989; 81(4):210-2. PubMed ID: 2474229
[TBL] [Abstract][Full Text] [Related]
54. Effects of interleukin-3 following chemotherapy of non-Hodgkin's lymphoma. A prospective, controlled phase I/II study.
Hovgaard DJ; Nissen NI
Eur J Haematol; 1995 Feb; 54(2):78-84. PubMed ID: 7698300
[TBL] [Abstract][Full Text] [Related]
55. Pharmacokinetics of subcutaneous recombinant human granulocyte colony-stimulating factor in children.
Stute N; Santana VM; Rodman JH; Schell MJ; Ihle JN; Evans WE
Blood; 1992 Jun; 79(11):2849-54. PubMed ID: 1375115
[TBL] [Abstract][Full Text] [Related]
56. Recombinant granulocyte colony-stimulating factor (rG-CSF). A review of its pharmacological properties and prospective role in neutropenic conditions.
Hollingshead LM; Goa KL
Drugs; 1991 Aug; 42(2):300-30. PubMed ID: 1717226
[TBL] [Abstract][Full Text] [Related]
57. Direct and indirect effects of recombinant human granulocyte-colony stimulating factor on in vitro colony formation of human bladder cancer cells.
Shameem IA; Kurisu H; Matsuyama H; Shimabukuro T; Naito K
Cancer Immunol Immunother; 1994 Jun; 38(6):353-7. PubMed ID: 7515769
[TBL] [Abstract][Full Text] [Related]
58. Granulocyte colony-stimulating factor versus placebo in addition to penicillin G in a randomized blinded study of gram-negative pneumonia sepsis: analysis of survival and multisystem organ failure.
Smith WS; Sumnicht GE; Sharpe RW; Samuelson D; Millard FE
Blood; 1995 Aug; 86(4):1301-9. PubMed ID: 7543303
[TBL] [Abstract][Full Text] [Related]
59. Mechanism of protective effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) on Pseudomonas infection.
Matsumoto M; Tamura M; Matsubara S; Matsuno T; Ono M; Yokota T
Microbiol Immunol; 1991; 35(6):461-74. PubMed ID: 1717812
[TBL] [Abstract][Full Text] [Related]
60. Fatal hematophagic histiocytosis after granulocyte-macrophage colony-stimulating factor and chemotherapy for high-grade malignant lymphoma.
Risti B; Flury RF; Schaffner A
Clin Investig; 1994 Jun; 72(6):457-61. PubMed ID: 7950158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
